Latest California Healthline Stories
As Insurers Struggle With GLP-1 Drug Costs, Some Seek To Wean Patients Off
Conventional wisdom says GLP-1 drugs must be taken indefinitely to maintain weight loss. But a growing number of researchers, payers, and providers are challenging that consensus and exploring whether — and how — to taper patients off expensive GLP-1 drugs.
Watch: How Controversies Over Vaccine Changes Affect You
Céline Gounder, KFF Health News’ editor-at-large for public health, discusses leadership changes at the Centers for Disease Control and Prevention and concerns over vaccine policy.
Do Pediatricians Recommend Vaccines To Make a Profit? There’s Not Much Money in It
Four pediatricians said evidence-based science and medicine and a desire to keep kids healthy drive doctors’ childhood vaccination recommendations. And while pediatric practices might make money immunizing privately insured children, most practices likely break even or lose money from providing the shots.
Changes at NIH Give Political Appointees Greater Power To Fund or Block Research
The National Institutes of Health’s long-held standard of peer review for grantmaking has been subverted by President Donald Trump and NIH Director Jay Bhattacharya, who gave unprecedented power to politicos, NIH workers say.
At CDC, Worries Mount That Agency Has Taken Anti-Science Turn
Health and Human Services Secretary Robert F. Kennedy Jr.’s push to fire Centers for Disease Control and Prevention Director Susan Monarez is more than an administrative shake-up. It marks a major offensive by Kennedy to seize control of the agency and impose an anti-science agenda, public health leaders say.
When Hospitals and Insurers Fight, Patients Get Caught in the Middle
About 90,000 people spent months in limbo as central Missouri’s major, and often only, provider fought over insurance contracts. Patients getting caught in the crossfire of disputes has become a familiar complication, as about 8% of hospitals have left an insurer network since 2021. Trump administration policies could accelerate the trend.
Social Security Praises Its New Chatbot. Ex-Officials Say It Was Tested but Shelved Under Biden.
Social Security, under the leadership of a tech enthusiast, rolled out an artificial intelligence-powered chatbot to answer calls. But as beneficiaries complain about glitches, lawmakers and former officials ask whether it’s a preview of a less human agency at which rushed-out AI takes the place of pushed-out government workers.
Listen: As Kids Head Back to School, Parents Sort Out Confusion Over Vaccine Access
Confusion over federal immunization policy could have major implications for how families with private insurance and Medicaid pay for routine vaccinations. Some doctors are encouraging parents not to wait and get their children shots as soon as they are eligible.
An Insurer Agreed To Cover Her Surgery. A Politician’s Nudge Got the Bills Paid.
A kindergartner in Missouri needed eye surgery. Her insurer granted approval for her to see a specialist nearby, yet her parents were confused when they still owed more than $13,000. Then her uncle, a former state senator, reached out to a colleague who contacted the hospital and the insurer.
Blue States That Sued Kept Most CDC Grants, While Red States Feel Brunt of Trump Clawbacks
The Trump administration’s cuts of public health funds to state and local health departments had vastly uneven effects depending on the political leanings of where someone lives, a new KFF Health News analysis shows.